Welcome to our dedicated page for Terrascent news (Ticker: TSNDF), a resource for investors and traders seeking the latest updates and insights on Terrascent stock.
TerrAscend Corp. issues news as a North American cannabis operator with common shares traded on the TSX as TSND and on OTCQX as TSNDF. Coverage centers on financial results from continuing operations, retail and wholesale cannabis revenue, gross margin, EBITDA, cash flow, and capital allocation.
The company operates The Apothecarium and other dispensary locations, along with cultivation, processing, and manufacturing facilities in Pennsylvania, New Jersey, Maryland, Ohio, California, and Canadian retail. Recurring updates also cover brand licensing and product launches involving names such as Cookies, Kind Tree, Wana, Valhalla Confections, and TYSON 2.0, as well as refinancings, acquisitions, share repurchase activity, discontinued operations, and executive appointments.
TerrAscend (OTCQX: TSNDF) reported Q1 2026 continuing-operations results: net revenue $65.5M, gross margin 52.8%, GAAP net loss from continuing operations of $6.8M, and Adjusted EBITDA $17.4M (26.5% of revenue). The company generated $8.7M net cash from operations and $7.8M free cash flow.
The quarter marks the 15th consecutive positive operating cash-flow quarter and 11th consecutive quarter of positive free cash flow; cash and equivalents were $39.1M as of March 31, 2026.
TerrAscend (OTCQX: TSNDF) announced preliminary, unaudited Q1 2026 continuing-operations results: net revenue $65.5 million and gross profit margin 52.8%. Results exclude Michigan, which is reported as discontinued operations effective Q2 2025; all prior periods were restated.
The company reported flat G&A quarter-over-quarter and positive operating cash flow for the 15th consecutive quarter. A conference call is scheduled for May 7, 2026 at 8:00 a.m. ET and detailed Q1 financials will be released before market open that day.
TerrAscend (OTCQX: TSNDF) appointed Eric Jackson as Chief Financial Officer, effective April 27, 2026. Mr. Jackson brings more than two decades of finance and operational leadership, including 8+ years as EVP & CFO at American Signature and 14+ years in senior roles at L Brands. He holds a BS in Business and an MBA.
The company highlighted his experience in efficiency, margin expansion, liquidity management, and operational transformation as priorities for scaling the business.
TerrAscend (OTCQX: TSNDF) launched TYSON 2.0 products in Pennsylvania and Maryland on March 31, 2026, expanding distribution through Apothecarium dispensaries and third-party wholesale partners.
Initial SKUs include premium flower jars (3.5g, 14g, 28g) and high-potency vapes; additional formats are planned throughout 2026.
TerrAscend (OTCQX: TSNDF) reported Q4 2025 net revenue of $66.1M and full-year 2025 net revenue of $260.6M. Gross margin from continuing operations was >52% for Q4 and FY. Adjusted EBITDA was $16.7M in Q4 and $67.8M for FY 2025. Net cash from continuing operations was $8.3M in Q4 and $33.9M for FY; free cash flow was $6.6M in Q4 and $25.3M for FY. The company executed a $79M non-dilutive refinancing and advanced a strategic exit from Michigan, using proceeds to reduce debt.
TerrAscend (OTCQX: TSNDF) will host a conference call to discuss fourth quarter and full year results for the period ended December 31, 2025 on Thursday, March 12, 2026 at 5:00 p.m. Eastern Time. Financial results will be released the same day after market close. Call and webcast details are provided for investor access.
Webcast: https://app.webinar.net/EPJ9wXNjKl1 | Dial-in: 1-888-510-2154 | Replay: 1-289-819-1450 or 1-888-660-6345 (available until March 26, 2026, entry code 77201#).
TerrAscend (OTCQX: TSNDF) closed its acquisition of Union Chill, a Hunterdon County dispensary, expanding its New Jersey retail footprint to four dispensaries and supporting a consolidated network of 20 dispensaries across five U.S. states and Canada upon option exercise and conditions. The deal totals $13 million (a $9 million convertible-note option at 6.5% interest plus $4 million cash on exercise). Union Chill currently generates over $11 million in annualized revenue and the company says the asset is expected to be immediately accretive to EBITDA and cashflow.
The transaction conforms to New Jersey regulatory rules for diverse ownership and is positioned to integrate TerrAscend’s premium brands to drive sales and margins.
TerrAscend (OTCQX: TSNDF) announced an exclusive licensing agreement with Tyson 2.0, the cannabis brand founded by Mike Tyson, to launch Tyson 2.0 products in Maryland and Pennsylvania.
In Maryland TerrAscend will manufacture and distribute premium flower, vapes, and edibles. In Pennsylvania the lineup will include flower, vapes, concentrates, and troches sold through Apothecarium retail stores and the company's wholesale network. Products are expected to reach Apothecarium locations and select dispensaries in the new year. The announcement emphasizes brand partnership and state-by-state product rollouts.
TerrAscend (OTCQX: TSNDF) reported Q3 2025 results: Net revenue $65.1M, Gross margin 52.1% (up 110 bps YoY), Adjusted EBITDA $17.0M (26.1% margin) and GAAP net loss $9.9M from continuing operations. Cash and cash equivalents were $36.6M. The company generated $7.1M net cash from continuing operations and $4.9M free cash flow, marking the 13th and 9th consecutive quarters of positive cash flow respectively. During Q3 TerrAscend closed a $79M senior secured term loan refinancing and secured an additional uncommitted $35M facility for M&A. Management plans to divest Michigan assets by year-end to repay debt.
TerrAscend (OTCQX: TSNDF) rescheduled its third quarter 2025 earnings conference call to Thursday, November 6, 2025 at 8:30 a.m. ET. The company will report financial results for the quarter ended September 30, 2025 earlier that day in advance of the call. Investors can join via webcast or dial-in; a replay will be available until midnight ET on Thursday, November 20, 2025.
Conference details: Webcast: https://app.webinar.net/6dvVkb2k4bz. Dial-in: 1-888-510-2154. Replay numbers: 1-289-819-1450 or 1-888-660-6345 with entry code 73897#.